Recent human trials reveal BPC-157’s potential for tendon and joint recovery, with promising angiogenic effects and favorable safety profiles, though long-term risks remain uncertain. Emerging h...
The first human study on intravenous BPC-157 explores its potential for tendon and muscle repair, backed by preclinical evidence of angiogenic and anti-inflammatory effects. The groundbreaking human s...
Recent pilot studies indicate BPC-157 may safely accelerate healing of tendon and muscle tears, though FDA approval is pending and WADA monitors its use in sports. Emerging research on the peptide BPC...